A Setanoians

691 citations
15 papers · 588 · h-index 12

Impact in

  • Oncology top 10%
    • Cancer Treatment and Pharmacology
    • Colorectal Cancer Treatments and Studies
    • Cancer, Hypoxia, and Metabolism

Papers in

    • Cancer Treatment and Pharmacology 6
    • Colorectal Cancer Treatments and Studies 2
    • Cancer therapeutics and mechanisms 5

A Setanoians

15 papers receiving 574 citations

Peers

A Setanoians
Comparison fields: 5 of 71
  • Oncology 253
  • Cancer Research 97
  • Toxicology 20
  • Pharmacology 43
  • Molecular Biology 316
Replace Maura A. Kraynak with:
Maura A. Kraynak United States
Ronald Drengler United States
M. Mahjoubi France
M. Ravic United Kingdom
Jean-Pierre Bizzari France
J. H. M. Schellens Netherlands
JHM Schellens Netherlands
Kim Binger United States
Larry House United States
Timothy M. Lestingi United States
A Setanoians relative to Maura A. Kraynak United States Maura A. Kraynak's profile →
Citations per field
00.5×2.7×
Maura A. Kraynak · 1×
Citations per year

Countries citing papers authored by A Setanoians

Since Specialization
Citations

This map shows the geographic impact of A Setanoians's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Setanoians with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Setanoians more than expected).

Fields of papers citing papers by A Setanoians

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Setanoians. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Setanoians. The network helps show where A Setanoians may publish in the future.

Co-authors

The 25 scholars most cited alongside A Setanoians, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A Setanoians Line = papers co-authored together A Setanoians links everyone, so they are left out of the graph.

All Works

15 of 15 papers shown
#Work
1 2007191
2
Phase I and pharmacokinetic study of taxotere (RP 56976) administered as a 24-hour infusion.
1993123
3
Phase I and pharmacokinetic study of flavone acetic acid.
198770
4
Phase I and pharmacokinetic study of LM985 (flavone acetic acid ester).
198633
5 199632
6
Phase I and pharmacokinetic study of rhizoxin.
199225
7 199622
8 199221
9 199416
10 199216
11 198914
12 198812
13 19936
14 19846
15 19861

About A Setanoians

A Setanoians is a scholar working on Oncology, Molecular Biology, Pharmacology, Organic Chemistry and Pulmonary and Respiratory Medicine, having authored 15 papers that have together received 588 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (6 papers), Cancer therapeutics and mechanisms (5 papers), Colorectal Cancer Treatments and Studies (2 papers), Synthesis and Biological Evaluation (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Cancer Genomics and Diagnostics (1 paper) and Computational Drug Discovery Methods (1 paper). The work is most often cited by research in Oncology (253 citations), Cancer Research (97 citations), Toxicology (20 citations), Pharmacology (43 citations) and Molecular Biology (316 citations). A Setanoians has collaborated with scholars based in United Kingdom, Netherlands and Greece. Frequent co-authors include David Kerr, Marien Alet Graham, D. Bissett, J Cassidy, Peter D. Wilson, Jane A. Plumb, Stan B. Kaye, N Le Bail, Gordon Strathdee and Chris Twelves. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, British Journal of Cancer, JNCI Journal of the National Cancer Institute, Journal of Clinical Oncology and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact